Coherus Bolsters Top Team As It Prepares For Launches
Company Lines Up Ranibizumab, Adalimumab And On-Body Pegfilgrastim Biosimilars
Coherus is laying the pathway for future launches of biosimilars and novel biologics by strengthening its leadership team with a trio of appointments.
